Moonlake Immunotherapeutics Ag

This study tests the long-term safety and effectiveness of a drug called sonelokimab for people with psoriatic arthritis. About 1560 adults who finished a previous sonelokimab study will receive the drug as a shot under the skin. The goal is to see if the drug remains safe and he…

This study looks at the long-term safety and how well the drug sonelokimab works for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. It includes about 835 adults and teens who already completed an earlier sonelokimab study. Participants wil…

This study tests a drug called sonelokimab in 35 teens aged 12 to 17 with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. The main goals are to see how the drug moves through the body and if it is safe. Researchers will also check if it helps reduce sk…

This study tests a new injectable drug called sonelokimab for people with active psoriatic arthritis who haven't tried biologic treatments before. About 960 adults will receive either the drug or a placebo to see if it improves joint pain and swelling. The goal is to control the …